Philip Wang, M.D., Dr.Ph., directs the new Learning Health Systems Center at Brigham and Women’s Hospital (BWH); the Center helps systems collect and integrate data on patients’ outcomes to continuously improve access, quality, equity, and outcomes from their care. Phil completed his undergraduate degree in biochemistry, medical school, masters and doctoral degrees in epidemiology, as well as psychiatry residency and chief residency, all at Harvard University. He was a faculty member at HMS and BWH until 2006, when he went to serve as Deputy Director of the National Institute of Mental Health (NIMH), and then Deputy Medical Director and Director of Research for the American Psychiatric Association (APA) where he oversaw the recent text revision of DSM. He returned to HMS in 2019 and served as Chair and Chief of Psychiatry, as well as Chief Science Officer at Cambridge Health Alliance. He is currently Co-PI of an NIMH P50 ALACRITY Center grant, as well as an NIMH T32 Fellowship Training grant through the Harvard-T.H. Chan School of Public Health. He has also been awarded research grants from CMS, NIDA, AHRQ, and the Robert Wood Johnson Foundation. He has served on several NIH Study Sections, as well as the FDA Psychopharmacologic Drugs Advisory Committee, FDA Medical Devices Advisory Committee, and FDA Endocrinologic and Metabolic Drugs Advisory Committee.
Our Team
-
Philip Sung-En Wang, Dr. P.H., M.D.Director of the Center for Learning Health Systems, Brigham and Women’s Hospital, a teaching hospital of Harvard Medical School
-
Rachel Wood, PhDVP, Learning Health Systems
Rachel Wood, PhD, Vice President of Learning Health Systems for Discovery Behavioral Health, is a licensed clinical psychologist in the behavioral health field for more than twenty years. During her time at Discovery, she has provided direct service in various levels of care including outpatient and intensive outpatient and partial hospitalization programs, direct clinical care for adults and adolescents in PHP RTC and children in acute inpatient. In her current position, Rachel’s focus is to leverage technology to gather evidence to improve care, access, outcomes, and long-term recovery. Rachel implemented an app for alumni to provide ongoing education and support via connection with staff members and community members.
Rachel’s programs increase the frequency and intensity of support following discharge affording real-time intervention for at risk alumni. In March 2020 Dr. Wood launched Discovery’s mobile support apps allowing alumni and families to remain connected to program staff, receive educational content on mental health and offer and receive peer support following discharge. The app is an extension of the in-person alumni programs offered by Discovery to provide a supportive community that fosters long-term recovery. Rachel received her Doctor of Philosophy in Clinical Psychology and Master of Arts in Clinical Psychology from the California School of Professional Psychology, San Francisco. She completed the 1998 International Scholars Program at Imperial College London, England. Her dissertation was presented at the International Conference for the Psychology of Science & Technology.
-
John Peloquin, Ph.D., MBAPast President & Chief Executive Officer, Discovery Behavioral Health
John Peloquin is a visionary in revolutionizing measurement-based care, setting a new standard for relapse prevention at Discovery so more patients can experience meaningful, sustained recovery. John has served as president and CEO since the company’s inception in 2018, when he facilitated the merger of Cliffside Malibu addiction centers with the Center for Discovery to form Discovery Behavioral Health. Under his leadership, Discovery has become a national leader in leveraging its growing database of quantified patient experiences to deliver tailored treatment that leads to greater patient success.
With John’s focus on the total journey of care, Discovery developed a first-of-its-kind tracking and assessment platform, Discovery365™, that provides patient support and monitoring beyond treatment to reduce the risk of relapse.
John’s experience in behavioral healthcare spans decades. He served as CEO of Cliffside Malibu, a network of addiction recovery centers ahead of the merger. He also led Acadia Healthcare’s national outpatient division, which nearly doubled in size under his leadership; chief administrative officer/director of operations at Vital Imaging and division president of CRC Health Group, one of the nation’s largest behavioral healthcare providers.
John leadership challenges the industry’s unacceptably high relapse standards to provide care that more often leads to the outcome that truly matters: a live well-lived.
-
Matthew Ruble, MDChief Medical Officer
Dr. Matthew Ruble is advancing behavioral health care by harnessing the power – and data – from tens of thousands of patient experiences to drive innovation in treatment and ultimately improve outcomes and lives.
As chief medical officer, Dr. Ruble is dedicated to education/training, research and collaboration among payers and providers. His collaboration with Mass General Brigham led to external, academic validation of Discovery’s clinical outcomes and national leadership in setting a new standard for measurement-based care.
Dr. Ruble works to elevate the needs of patients, providers and payers by decreasing barriers to care and prioritizing value while ensuring clinical quality.
Prior to joining Discovery, he served as national medical director at Human and was part of the team that reviewed and advised Humana leadership on all behavioral health technology/innovations for potential investment/acquisition and implementation.
A former faculty member of Harvard Medical School for nearly 20 years, Dr. Ruble also served as the Director of Behavioral Health and the Associate Training Director for the Adult Psychiatry residency training program at the Cambridge Health Alliance.
Dr. Ruble earned his Bachelor of Science degree from Simpson College in Indianola, Iowa. He completed an Infectious Disease research Fellowship at Brown University’s School of Medicine before completing his MD at the Carver School of Medicine at the University of Iowa. He then attended Harvard Medical School to intern at the Department of Medicine and to complete his residency at the Department of Psychiatry. Dr. Ruble became Chief Resident of Psychopharmacology at Cambridge Health Alliance. He then completed his Fellowship in Medical Education at the Academy of Harvard Medical School.